Resistance mutation info of target
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T89055 | ||||
Target Name | Dual specificity mitogen-activated protein kinase kinase 2 (MAP2K2) | Target Info | |||
Gene Name | MAP2K2 | ||||
Species | Homo sapiens | ||||
Uniprot ID | MP2K2_HUMAN | ||||
Sequence | MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQ KAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQ GTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL KMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV [Homo sapiens] |
||||
Drug Resistance Mutation and Corresponding Drugs | |||||
Mutation Info | Missense: C125S | ||||
Mutation Info | Missense: E207K | ||||
Mutation Info | Missense: F57C | ||||
Mutation Info | Missense: L46F | ||||
Mutation Info | Missense: N126D | ||||
Mutation Info | Missense: Q60P | ||||
Mutation Info | Missense: V215E | ||||
Mutation Info | Missense: V35M | ||||
Reference | |||||
Ref 555849 | ERK inhibition overcomes acquired resistance to MEK inhibitors. Mol Cancer Ther. 2012 May;11(5):1143-54. doi: 10.1158/1535-7163.MCT-11-1010. Epub 2012 Mar 8. | ||||
Ref 555981 | The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov. 2014 Jan;4(1):94-109. doi: 10.1158/2159-8290.CD-13-0617. Epub 2013 Nov 21. | ||||
Ref 555982 | MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition. Cancer Discov. 2014 Jan;4(1):61-8. doi: 10.1158/2159-8290.CD-13-0631. Epub 2013 Nov 21. | ||||
Ref 555991 | BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clin Cancer Res. 2014 Apr 1;20(7):1965-77. doi: 10.1158/1078-0432.CCR-13-3122. Epub 2014 Jan 24. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.